Bank of America’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-19,959
| Closed | -$103K | – | 7743 |
|
|
2019
Q2 | $103K | Buy |
19,959
+4,471
| +29% | +$20.1K | ﹤0.01% | 5998 |
|
|
2019
Q1 | $57K | Sell |
15,488
-22,903
| -60% | -$99.2K | ﹤0.01% | 6149 |
|
|
2018
Q4 | $236K | Buy |
38,391
+6,803
| +22% | +$41.5K | ﹤0.01% | 5421 |
|
|
2018
Q3 | $185K | Buy |
31,588
+25,261
| +399% | +$126K | ﹤0.01% | 5533 |
|
|
2018
Q2 | $27K | Sell |
6,327
-2,980
| -32% | -$15K | ﹤0.01% | 6419 |
|
|
2018
Q1 | $41K | Sell |
9,307
-8,389
| -47% | -$37.4K | ﹤0.01% | 6118 |
|
|
2017
Q4 | $93K | Sell |
17,696
-2,109
| -11% | -$12.9K | ﹤0.01% | 5778 |
|
|
2017
Q3 | $121K | Buy |
19,805
+7,824
| +65% | +$49.5K | ﹤0.01% | 5603 |
|
|
2017
Q2 | $86K | Sell |
11,981
-3,476
| -22% | -$21.4K | ﹤0.01% | 5661 |
|
|
2017
Q1 | $82K | Buy |
15,457
+7,151
| +86% | +$48.3K | ﹤0.01% | 5713 |
|
|
2016
Q4 | $60K | Buy |
8,306
+1,518
| +22% | +$12.3K | ﹤0.01% | 5854 |
|
|
2016
Q3 | $63K | Buy |
6,788
+121
| +2% | +$1K | ﹤0.01% | 5648 |
|
|
2016
Q2 | $42K | Buy |
6,667
+2,482
| +59% | +$16K | ﹤0.01% | 5913 |
|
|
2016
Q1 | $24K | Sell |
4,185
-7,617
| -65% | -$28.6K | ﹤0.01% | 6073 |
|
|
2015
Q4 | $66K | Sell |
11,802
-31,566
| -73% | -$209K | ﹤0.01% | 5915 |
|
|
2015
Q3 | $367K | Sell |
43,368
-6,478
| -13% | -$110K | ﹤0.01% | 5000 |
|
|
2015
Q2 | $754K | Buy |
49,846
+26,503
| +114% | +$383K | ﹤0.01% | 4353 |
|
|
2015
Q1 | $374K | Buy |
23,343
+19,943
| +587% | +$355K | ﹤0.01% | 4509 |
|
|
2014
Q4 | $61K | Sell |
3,400
-14,523
| -81% | -$181K | ﹤0.01% | 6219 |
|
|
2014
Q3 | $180K | Buy |
17,923
+7,018
| +64% | +$85.1K | ﹤0.01% | 5482 |
|
|
2014
Q2 | $171K | Buy |
10,905
+5,274
| +94% | +$74.7K | ﹤0.01% | 5690 |
|
|
2014
Q1 | $104K | Buy |
5,631
+5,615
| +35,094% | +$113K | ﹤0.01% | 5973 |
|
|
2013
Q4 | $0 | Buy |
+16
| New | +$325 | ﹤0.01% | 8285 |
|
Other funds holding PETX
Bank of America's PETX Position: Q3 2019 in Review
Bank of America sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 19,959 shares — an estimated $103K sold.
Bank of America first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $754K in Q2 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Bank of America reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Bank of America sold 19,959 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $103K.
- Bank of America first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
- Bank of America's Aratana Therapeutics, Inc. position peaked at $754K in Q2 2015.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.